In an investigation of a new class of deoxyribonucleic acid (DNA)-intercalating antitumor agents, novel acridinyl-substituted uracils have been synthesized and evaluated for activity against L1210 leukemia in vivo, and against bacteria and fungus. These compounds were prepared by the novel enamine reaction between 9-chloroacridines and 6-aminouracils. The positional effects of substituents on the acridine
在对一类新型的插入
脱氧核糖核酸(DNA)的
抗肿瘤药物的研究中,合成了新的cri啶基取代的尿
嘧啶,并评估了其在体内对L1210白血病以及对细菌和真菌的活性。这些化合物是通过9-
氯ac啶和6-
氨基尿
嘧啶之间的新型烯胺反应制备的。取代基在the啶环上的位置效应表明,在the啶环的3或6位带有吸电子基团的化合物活性最高。